Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

A research team, affiliated with UNIST has unveiled soft self-standing protein hydrogels that selectively deliver drugs, ...

College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, P. R. China National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi ...

Antigen processing and presentation is the mechanism by which whole antigens are degraded and loaded onto MHC molecules for display on the cell surface for recognition by T cells. Both macrophages ...

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Recognition of specific antigen through the B-cell receptor (BCR) stimulates the activation of B cells, which ultimately results in the production of high-affinity antibodies and the provision of ...

Our data support the concept that antigen-specific Tregs can be prepared ... For FoxP3/CD3 staining, sections were paraformaldehyde-fixed and permeabilized using True-Nuclear Transcription factor ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Abstract Proteins, inherently biocompatible and biodegradable, face a challenge in forming stable hydrogels without external chemical crosslinkers ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge domain (HD) and the transmembrane domain (TMD) between the ...

Curium, a world leader in nuclear medicine, today announced that in Estonia, Finland, Latvia, and Sweden, PYLCLARI® is now available for patients with prostate cancer. PYLCLARI® (INN: Piflufolastat (1 ...